Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Predictive Factors of Sustained Remission of Crohn's Disease After Stopping Infliximab

NCT00571337 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT00571337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Predictive Factors of Sustained Remission of Crohn's Disease After Stopping Infliximab
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
July 31, 2010
Enrollment
126 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease